Exploring the untapped pharmacological potential of imidazopyridazines-Reference-Cited by-同舟云学术

Exploring the untapped pharmacological potential of imidazopyridazines

Published:2024 Issue:6 Volume:14 Page:3972-3984
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Malik M. Shaheer¹^ORCID,Alshareef Hossa F.¹,Alfaidi Khalid A.¹,Ather Hissana²,Abduljaleel Zainularifeen³,Hussein Essam M.¹⁴^ORCID,Moussa Ziad⁵^ORCID,Ahmed Saleh A.¹⁴^ORCID

Affiliation:

1. Department of Chemistry, Faculty of Science, Umm Al-Qura University, Makkah 21955, Saudi Arabia

2. Science and Technology Unit, Umm Al-Qura University, Makkah 21955, Saudi Arabia

3. Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid University (KKU), Abha 62529, Saudi Arabia

4. Department of Chemistry, Faculty of Science, Assiut University, 71516 Assiut, Egypt

5. Department of Chemistry, College of Science, United Arab Emirates University, P.O. Box 15551, Al Ain, United Arab Emirates

Abstract

Imidazopyridazines are fused heterocycles, like purines, with a pyridazine ring replacing the pyrimidine ring in purines.

Funder

Umm Al-Qura University

United Arab Emirates University

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/RA/D3RA07280K

Reference65 articles.

1. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications

2. Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals

3. Prescribed drugs containing nitrogen heterocycles: an overview

4. The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization

5. Clofarabine in leukemia